We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Immune Abnormalities Meet Diagnostic Criteria for Myalgic Encephalomyelitis

By LabMedica International staff writers
Posted on 16 Jan 2014
Immunological abnormalities have been identified in Myalgic Encephalomyelitis, also known as Chronic Fatigue Syndrome (ME/CFS) patients and significant developments have been made to the diagnostic criteria

Potential immunological markers have not been assessed in patients fulfilling these latest clinical requirements and therefore there is a need to evaluate immunological parameters in patients that also fulfill the latest diagnostic criteria available known as the International Consensus Criteria (ICC). More...


Immunologists at Griffith University (Gold Coast, Australia) recruited 63 participants of which 41 were ME/CFS patients and 22 were healthy controls. Whole blood samples were collected from all participants. With the exception of Natural Killer (NK) cell phenotyping experiments, whole blood was used for all phenotyping studies.

For all flow cytometer experiments, the monoclonal antibodies were fluorescently labeled with fluorescein isothiocyanate, phycoerythrin, allophycocyanin and peridinin chlorophyll, and analysis was performed on a four-color flow cytometer. The activity of NK cells was measured using a well-known flow cytometric method stained with annexin V and 7-AAD (Becton Dickinson (BD); San Diego, CA, USA) and analyzed on the BD fluorescence-activated cell sorting (FACS) Calibur flow cytometer.

In patients with ME/CFS, NK cell activity was significantly reduced in comparison to healthy controls. Measures of NK cell lytic proteins did not yield any significance difference between the groups. A significant increase in regulatory T-cells (Tregs) was observed ME/CFS patients in comparison to healthy controls. A significant decrease in cluster of differentiation CD39+ Tregs was observed in one group of ME/CFS patients in comparison to healthy controls. No significant differences were observed in B-cells, NK cells and plasmacytoid and myeloid (DC) phenotypes.

The authors concluded that differences could be found in human neutrophil antigens and expression of natural killer cell receptors between patient groups. Highly significant correlations were also found between physical status and some immune parameters in ICC defined patients. This preliminary investigation on different diagnostic criteria suggests that the ICC may be more effective in detecting salient differences in the immune system. The study was published on November 14, 2013, in the Journal of Molecular Biomarkers & Diagnosis.

Related Links:

Griffith University
Becton Dickinson 



Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
C-Reactive Protein Assay
OneStep C-Reactive Protein (CRP) RapiCard InstaTest
New
PSA Test
Humasis PSA Card
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Pathology

view channel
Image: AI-analyzed images from the FDM microscope show platelet clumps in motion (Photo courtesy of Hirose et al CC-BY-ND)

AI Microscope Spots Deadly Blood Clots Before They Strike

Platelets are small blood cells that act as emergency responders in the body, rushing to areas of injury to help stop bleeding by forming clots. However, sometimes platelets can overreact, leading to complications.... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.